Can cognitive enhancers reduce the risk of falls in older people with Mild Cognitive Impairment? A protocol for a randomised controlled double blind trial

BackgroundOlder adults with cognitive problems have a higher risk of falls, at least twice that of cognitively normal older adults. The consequences of falls in this population are very serious: fallers with cognitive problems suffer more injuries due to falls and are approximately five times more likely to be admitted to institutional care. Although the mechanisms of increased fall risk in cognitively impaired people are not completely understood, it is known that impaired cognitive abilities can reduce attentional resource allocation while walking. Since cognitive enhancers, such as cholinesterase inhibitors, improve attention and executive function, we hypothesise that cognitive enhancers may reduce fall risk in elderly people in the early stages of cognitive decline by improving their gait and balance performance due to an enhancement in attention and executive function.Method/DesignDouble blinded randomized controlled trial with 6 months follow-up in 140 older individuals with Mild Cognitive Impairment (MCI). Participants will be randomized to the intervention group, receiving donepezil, and to the control group, receiving placebo. A block randomization by four and stratification based on fall history will be performed. Primary outcomes are improvements in gait velocity and reduction in gait variability. Secondary outcomes are changes in the balance confidence, balance sway, attention, executive function, and number of falls.DiscussionBy characterizing and understanding the effects of cognitive enhancers on fall risk in older adults with cognitive impairments, we will be able to pave the way for a new approach to fall prevention in this population. This RCT study will provide, for the first time, information regarding the effect of a medication designed to augment cognitive functioning have on the risk of falls in older adults with Mild Cognitive Impairment. We expect a significant reduction in the risk of falls in this vulnerable population as a function of the reduced gait variability achieved by treatment with cognitive enhancers. This study may contribute to a new approach to prevent and treat fall risk in seniors in early stages of dementia.Trial RegistrationThe protocol for this study is registered with the Clinical Trials Registry, identifier number: NCT00934531 http://www.clinicaltrials.gov

[1]  S. Lord,et al.  Postural stability and associated physiological factors in a population of aged persons. , 1991, Journal of gerontology.

[2]  J. Kaye,et al.  Talking while walking , 1997, Neurology.

[3]  T D Cooke,et al.  The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. , 1991, Arthritis and rheumatism.

[4]  J. Touchon,et al.  Mild cognitive impairment: conceptual basis and current nosological status , 2000, The Lancet.

[5]  O. Beauchet,et al.  Dual-task-related gait changes in transitionally frail older adults : The type of the walking-associated cognitive task matter , 2005 .

[6]  Rose Anne Kenny,et al.  Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial , 2003, BMJ : British Medical Journal.

[7]  Pamela W. Duncan,et al.  Guideline for the Prevention of Falls in Older Persons , 2001 .

[8]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[9]  T. Finucane.  Cholinesterase inhibitors for Alzheimer's disease , 2002, The Lancet.

[10]  P. Dieppe,et al.  Osteoarthritis: definitions and criteria. , 1989, Annals of the rheumatic diseases.

[11]  David A Ganz,et al.  Monitoring Falls in Cohort Studies of Community‐Dwelling Older People: Effect of the Recall Interval , 2005, Journal of the American Geriatrics Society.

[12]  R. Simes,et al.  An improved Bonferroni procedure for multiple tests of significance , 1986 .

[13]  C. J. V. van Uden,et al.  Test-retest reliability of temporal and spatial gait characteristics measured with an instrumented walkway system (GAITRite®) , 2004, BMC musculoskeletal disorders.

[14]  M. Montero‐Odasso,et al.  CAN COGNITIVE ENHANCERS REDUCE THE RISK OF FALLS IN PEOPLE WITH DEMENTIA? AN OPEN‐LABEL STUDY WITH CONTROLS , 2009, Journal of the American Geriatrics Society.

[15]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[16]  Canadian study of health and aging: study methods and prevalence of dementia. , 1994, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[17]  R J Harvey,et al.  Donepezil for dementia due to Alzheimer's disease. , 2006, The Cochrane database of systematic reviews.

[18]  G Denes,et al.  Concepts and facts in calculation. , 1994, Brain : a journal of neurology.

[19]  K. Davis.  Cholinesterase Inhibitors in Alzheimer's Disease , 1994, Neuropsychopharmacology.

[20]  Alistair Burns,et al.  Mild cognitive impairment in older people , 2002, The Lancet.

[21]  Peter Graf,et al.  Increased Risk of Falling in Older Community-Dwelling Women With Mild Cognitive Impairment , 2008, Physical Therapy.

[22]  Anne B. Newman,et al.  Quantitative Measures of Gait Characteristics Indicate Prevalence of Underlying Subclinical Structural Brain Abnormalities in High-Functioning Older Adults , 2005, Neuroepidemiology.

[23]  M. Tinetti,et al.  A multifactorial intervention to reduce the risk of falling among elderly people living in the community. , 1994, The New England journal of medicine.

[24]  John H Hollman,et al.  Agreement between the GAITRite walkway system and a stopwatch-footfall count method for measurement of temporal and spatial gait parameters. , 2006, Archives of physical medicine and rehabilitation.

[25]  L. Nyberg,et al.  “Stops walking when talking” as a predictor of falls in elderly people , 1997, The Lancet.

[26]  P A Parmelee,et al.  Geriatric Depression Scale , 2002 .

[27]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[28]  C MacKnight,et al.  Estimating the Prevalence of Dementia in Elderly People: A Comparison of the Canadian Study of Health and Aging and National Population Health Survey Approaches , 2001, International Psychogeriatrics.

[29]  M. Tinetti,et al.  Risk factors for falls among elderly persons living in the community. , 1988, The New England journal of medicine.

[30]  J. Morris,et al.  Senile dementia of the Alzheimer's type: an important risk factor for serious falls. , 1987, Journal of gerontology.

[31]  Bastiaan R Bloem,et al.  Walking and Talking as Predictors of Falls in the General Population: The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.

[32]  B. Seltzer,et al.  Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. , 2004, Archives of neurology.

[33]  T. Hermana,et al.  Gait instability and fractal dynamics of older adults with a “ cautious ” gait : why do certain older adults walk fearfully ? , 2005 .

[34]  Luigi Ferrucci,et al.  Executive Function Correlates with Walking Speed in Older Persons: The InCHIANTI Study , 2005, Journal of the American Geriatrics Society.

[35]  R. Camicioli,et al.  Dual-tasks and walking fast: Relationship to extra-pyramidal signs in advanced Alzheimer disease , 2006, Journal of the Neurological Sciences.

[36]  M. Speechley,et al.  Use of the Berg Balance Scale for Predicting Multiple Falls in Community-Dwelling Elderly People: A Prospective Study , 2008, Physical Therapy.

[37]  H. Buschke,et al.  Walking while talking: effect of task prioritization in the elderly. , 2007, Archives of physical medicine and rehabilitation.

[38]  Orthopaedic Surgeons Panel On Falls Prevention.  Guideline for the Prevention of Falls in Older Persons , 2001 .

[39]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[40]  O. Beauchet,et al.  GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE , 2008, Journal of the American Geriatrics Society.

[41]  A. Vandervoort,et al.  Risk Factors for Falling among Community-Dwelling Veterans and Their Caregivers , 2005, Canadian Journal on Aging / La Revue canadienne du vieillissement.

[42]  M. Speechley,et al.  The Phone-FITT: a brief physical activity interview for older adults. , 2008, Journal of aging and physical activity.

[43]  R. Altman.  Criteria for the classification of osteoarthritis of the knee and hip. , 1987, Scandinavian journal of rheumatology. Supplement.

[44]  D. Bennett,et al.  Mild cognitive impairment in different functional domains and incident Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  Jeffrey M. Hausdorff,et al.  Walking is more like catching than tapping: gait in the elderly as a complex cognitive task , 2005, Experimental Brain Research.

[46]  M. Woollacott,et al.  Attention and the control of posture and gait: a review of an emerging area of research. , 2002, Gait & posture.

[47]  P J Holliday,et al.  Psychological indicators of balance confidence: relationship to actual and perceived abilities. , 1996, The journals of gerontology. Series A, Biological sciences and medical sciences.

[48]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[49]  Jeffrey M. Hausdorff.  Gait variability: methods, modeling and meaning , 2005, Journal of NeuroEngineering and Rehabilitation.

[50]  Anne Whitehead,et al.  Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses , 2006, BMJ : British Medical Journal.

[51]  Jeffrey M. Hausdorff,et al.  Effects of Pharmacological Therapy on Gait and Cognitive Function in Depressed Patients , 2007, Clinical neuropharmacology.

[52]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[53]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[54]  F. Shaw,et al.  Prevention of falls in older people with dementia , 2007, Journal of Neural Transmission.

[55]  John Breitner,et al.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.

[56]  P. Pahapill,et al.  The pedunculopontine nucleus and Parkinson's disease. , 2000, Brain : a journal of neurology.

[57]  M. Morris,et al.  Concurrent related validity of the GAITRite walkway system for quantification of the spatial and temporal parameters of gait. , 2003, Gait & posture.

[58]  L. E. Powell,et al.  The Activities-specific Balance Confidence (ABC) Scale. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.

[59]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[60]  Jeffrey M. Hausdorff,et al.  The role of executive function and attention in gait , 2008, Movement disorders : official journal of the Movement Disorder Society.

[61]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[62]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[63]  M. Montero‐Odasso.  THE VALUE OF GAIT VELOCITY TEST FOR HIGH‐FUNCTION POPULATIONS , 2006, Journal of the American Geriatrics Society.

[64]  M. Speechley,et al.  Injurious Falls Are Associated with Lower Household but Higher Recreational Physical Activities in Community-Dwelling Older Male Veterans , 2008, Gerontology.

[65]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.